Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04208178 |
| Title | Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation (EPIK-B2) |
| Acronym | EPIK-B2 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ITA | FRA | ESP | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Highlands Oncology Group | Fayetteville | Arkansas | 72703 | United States | Details | |
| University of California LA | Los Angeles | California | 90095 | United States | Details | |
| Novartis Investigative Site | Leuven | 3000 | Belgium | Details | ||
| Novartis Investigative Site | Liege | 4000 | Belgium | Details | ||
| Novartis Investigative Site | Chang Chun | Jilin | 130021 | China | Details | |
| Novartis Investigative Site | Shanghai | 200032 | China | Details | ||
| Novartis Investigative Site | Saint-Cloud | Hauts De Seine | 92210 | France | Details | |
| Novartis Investigative Site | Saint Herblain | 44805 | France | Details | ||
| Novartis Investigative Site | Firenze | FI | 50134 | Italy | Details | |
| Novartis Investigative Site | Kuala Lumpur | 59100 | Malaysia | Details | ||
| Novartis Investigative Site | Hospitalet de LLobregat | Catalunya | 08907 | Spain | Details |